What is Unity Biotechnology 5-Year Share Buyback Ratio?
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
5-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past five years. It is calculated as the annualized percentage change in shares outstanding from five years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Unity Biotechnology's current 5-Year Share Buyback Ratio was -35.50%.
UBX's 5-Year Share Buyback Ratio is ranked worse than 83.61% of 1153
companies
in the Biotechnology industry
Industry Median: -9.9
vs UBX: -35.50
Competitive Comparison of Unity Biotechnology's 5-Year Share Buyback Ratio
For the Biotechnology subindustry, Unity Biotechnology's 5-Year Share Buyback Ratio, along with its competitors' market caps and 5-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Unity Biotechnology's 5-Year Share Buyback Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Unity Biotechnology's 5-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Unity Biotechnology's 5-Year Share Buyback Ratio falls into.
Unity Biotechnology 5-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from five years ago to the current year. The annualized percentage change is calculated with least-square regression based on the latest six years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
Unity Biotechnology (NAS:UBX) 5-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Unity Biotechnology 5-Year Share Buyback Ratio Related Terms
Thank you for viewing the detailed overview of Unity Biotechnology's 5-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
UBX has been successfully added to your